BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10899252)

  • 1. Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis.
    Hafeez I; Muers MF; Murphy SA; Evans EG; Barton RC; McWhinney P
    Thorax; 2000 Aug; 55(8):717-9. PubMed ID: 10899252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by Pulmonary Mycobacterium-avium complex disease.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
    Intern Med; 2005 Mar; 44(3):246-50. PubMed ID: 15805716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential interaction between itraconazole and clarithromycin.
    Auclair B; Berning SE; Huitt GA; Peloquin CA
    Pharmacotherapy; 1999 Dec; 19(12):1439-44. PubMed ID: 10600094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic necrotising pulmonary aspergillosis treated with itraconazole.
    Elliott JA; Milne LJ; Cumming D
    Thorax; 1989 Oct; 44(10):820-1. PubMed ID: 2556808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal hemoptysis from invasive Aspergillus niger in a patient with cavitary lung disease and Mycobacterium avium complex infection.
    Gifford AH; Lahey T; Fordham Von Reyn C
    Med Mycol; 2006 Sep; 44(6):557-60. PubMed ID: 16966174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Tracheobronchial Aspergillosis with Bronchial Ulcers Complicated by Nontuberculous Mycobacterial Disease.
    Kanai T; Samejima Y; Noda Y; Kim SH; Tamura K; Umakoshi T; Shimizu K; Kashiwa Y; Morishita H; Ueda K; Kawahara K; Yaguchi T; Matsuoka H
    Intern Med; 2020 May; 59(9):1189-1194. PubMed ID: 32009092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
    Moon SM; Jhun BW; Lee H; Park HY; Jeon K; Lee SY; Koh WJ
    J Infect Chemother; 2017 Sep; 23(9):658-660. PubMed ID: 28284662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pulmonary aspergillosis in an insulin-dependent diabetic.
    Janes SM; Barker KF; Mak V; Bell D
    Respir Med; 1998 Jul; 92(7):972-5. PubMed ID: 10070575
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute pancreatitis in a patient treated with micafungin.
    Sato K; Hayashi M; Utsugi M; Ishizuka T; Takagi H; Mori M
    Clin Ther; 2007 Jul; 29(7):1468-73. PubMed ID: 17825698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM].
    Ito N; Kudo S
    Jpn J Antibiot; 2002 Dec; 55(6):893-7. PubMed ID: 12664928
    [No Abstract]   [Full Text] [Related]  

  • 11. Invasive Aspergillus niger with fatal pulmonary oxalosis in chronic obstructive pulmonary disease.
    Kimmerling EA; Fedrick JA; Tenholder MF
    Chest; 1992 Mar; 101(3):870-2. PubMed ID: 1541168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.
    Moon SM; Park HY; Jeong BH; Jeon K; Lee SY; Koh WJ
    Antimicrob Agents Chemother; 2015 Jan; 59(1):663-5. PubMed ID: 25313207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium xenopi infection and aspergilloma.
    Johnston ID
    Tubercle; 1988 Jun; 69(2):139-43. PubMed ID: 3055575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of pulmonary aspergillosis successfully treated with itraconazole].
    Watanabe T; Kuriyama K; Kamei K
    Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung cancer occurring with Mycobacterium xenopi and Aspergillus.
    Souilamas R; Danel C; Chauffour X; Riquet M
    Eur J Cardiothorac Surg; 2001 Jul; 20(1):211-3. PubMed ID: 11423302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidural aspergillosis secondary to lung aspergilloma despite long-term itraconazole treatment].
    Jeanrot C; Guigui P; Groussard O; Deburge A
    Rev Chir Orthop Reparatrice Appar Mot; 2001 Oct; 87(6):596-600. PubMed ID: 11685151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination?
    Böllert FG; Sime PJ; MacNee W; Crompton GK
    Thorax; 1994 May; 49(5):521-2. PubMed ID: 8016779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pulmonary aspergillosis with intraspinal extension in a non-immunocompromised host. A case report.
    Cherian SM; Keshavamurthy S; Madhu Sankar N; Kurian VM; Sivaraman A; Verghese S; Cherian KM
    J Cardiovasc Surg (Torino); 2002 Apr; 43(2):291-3. PubMed ID: 11887073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].
    Milleron B; Roger V; Roux P; Lebreton C; Koeger A; Dupont B; Akoun G
    Rev Pneumol Clin; 1990; 46(4):175-7. PubMed ID: 1966029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.